The adhesion molecule L-selectin is expressed on the cell surface of lymphocytes and mediates their migration from the bloodstream into lymph nodes. L-selectin is able to recognize four glycoprotein ligands, three of which -Sgp50, Sgp90 and Sgp200 -are sulphated, bind specifically to L-selectin and are synthesized by the high endothelial venules of the peripheral and mesenteric lymph nodes. One of these three sulphated L-selectin ligands, Sgp90, has been shown to be identical to the known surface marker CD34 and is expressed on the cell surface of endothelial cells. The cDNA encoding Sgp50 has been cloned, and its product, which has been designated GlyCAM-1, is secreted. The third ligand, Sgp200, is both secreted and cell-associated. We have investigated how the expression of these sulphated glycoproteins is regulated during an immune response.
Background
Lymphocyte migration from the bloodstream into secondary lymphoid organs, such as the peripheral and mesenteric lymph nodes and Peyer's patches, is a prerequisite for the generation of an efficient immune response. This migration is initiated by adhesive interactions between lymphocyte-homing receptors and their respective ligands on specialized post-capillary high endothelial venules (HEVs; [1, 2] ). The L-selectin homing receptor is required for the migration of cells to peripheral lymph nodes [3, 4] , and it seems that this lectin-like adhesion molecule is also involved in lymphocyte migration to mesenteric lymph nodes and, to a lesser extent, to Peyer's patches [5, 6] .
Until recently, the ligands present on the HEV surface that are recognized by L-selectin had been poorly defined. The production of antibodies to murine HEV [7, 8] and the construction of a chimeric L-selectinhuman immunoglobulin G fusion protein (L-selectinIgG; [9] ), both of which inhibit lymphocyte binding to HEV in vitro and leukocyte migration in vivo, have allowed the molecular identification of three L-selectin ligands [10] [11] [12] [13] . Two of the three ligands were initially identified by Imai et al. [14] as sulphated glycoproteins of molecular weights 50 kD and 90 kD that specifically bind to L-selectin. The cDNA encoding the 50 kD molecule has been cloned, and its product designated GlyCAM-1 [10] ; the 90 kD species was shown to be identical to the known cell-surface marker molecule CD34 [12] . Another ligand, MAdCAM-1 not only interacts with Lselectin [15] , but also serves as a ligand for integrin a4p7-bearing lymphocytes that migrate to mesenteric lymph nodes and Peyer's patches [16] , and thus, unlike GlyCAM-1 and CD34, is not specific for L-selectin. In all three cases, these endothelial ligands contain highly O-glycosylated mucin-like domains that seem to serve as scaffolds for the presentation of carbohydrate ligands to the lectin domain of L-selectin. Whereas CD34 is a type I transmembrane protein that is expressed on the luminal surface of the HEV, GlyCAM-1 is secreted from HEV cells in vitro and into the bloodstream in vivo, where it is active as a soluble L-selectin ligand that can block the adherence of lymphocytes to HEVs [1] . In the same studies, we showed that there was a third sulphated ligand that specifically recognizes L-selectin, which was made in and found in normal mouse serum; some Sgp 2 00, however, is present in a cell-associated form. Furthermore, although secreted GlyCAM-1 and Sgp200 are down-regulated 3-4 days after the induction of an immune response, the levels of CD34 and Sgp200 associated with peripheral-lymph-node lysates remain largely unaltered throughout the course of the immune response. Decreases in the levels of secreted GlyCAM-1 and Sgp200 are only seen in lymph nodes exposed to antigen. Following the decline in the amount of secreted L-selectin ligands, more lymphocytes migrate to antigen-primed peripheral lymph nodes, but this migration remains L-selectin dependent. We suggest that the secreted forms of the L-selectin ligands Sgp200 and GlyCAM-1 act as modulators of cell adhesion, and that cell-associated CD34 and Sgp200 are the ligands that mediate the initial loose binding of lymphocytes to HEVs.
Results

L-selectin-lgG precipitates at least three sulphated glycoproteins
It was originally shown that L-selectin-IgG recognized two sulphated glycoproteins, GlyCAM-1 and CD34, [141. Subsequent experiments, performed by labeling peripheral and mesenteric lymph nodes in vivo, demonstrated that a third sulphated glycoprotein, Sgp 2 0 0 , was immunoprecipitated by L-selectin-IgG [11] . When peripheral and mesenteric lymph nodes were labeled in vitro with [3 5 S]sodium sulphate and the lysates incubated with L-selectin-IgG, these same three proteins were immunoprecipitated (Fig. la, lanes 5 and 8) . The precipitation of all three proteins was inhibited by the addition of 10 mM EGTA (Fig. la, lanes 6 and 9) and fucoidan (data not shown), thus demonstrating that the precipitation requires the presence of Ca 2+ and is inhibitable by carbohydrates, two features that are diagnostic of L-selectin-ligand interactions. Polyclonal antisera recognizing either GlyCAM-1 or CD34 (Fig. lb, lanes 1-9) were unable to precipitate Sgp200. Radioimmunoprecipitations also revealed that Sgp200 was present in the supernatants of peripheral lymph node organ cultures (Figs 2 and 4 ) and, at low levels, in the serum of [3 5 S]sodium sulphateinjected mice, as was another sulphated L-selectin ligand of molecular weight -170-180 kD ( Fig.1 a, lane 2) . L-selectin-IgG thus recognizes at least three.sulphated glycoproteins, GlyCAM-1, CD34 and Sgp 2 0 0 . Gly-CAM-1 and Sgp200 are found in the supernatants and lysates of lymph node organ cultures as well as in serum, whereas CD34 is only found in the cultured lymph node lysate. These results also demonstrate that GlyCAM-1, CD34 and Sgp 2 00 are immunologically distinct.
Effects of an immune response on L-selectin ligands
To study the effects of an immune response on the expression of L-selectin ligands, animals were first primed with a topical application of oxazolone (a haptenating agent that is not antigenic itself but that derivatizes self . (a,b) The results of representative radioimmunoprecipitations from supernatants using L-selectin-lgG or anti-GlyCAM-1, respectively. (c) Radioimmunoprecipitations from lysates using L-selectin-lgG. (d) A graphical representation of the quantitated material from supernatants. (e) Quantification of materials from lysates. Gels were analyzed on a Fujix scanner and the amount of radioactivity in the total cell lysate (total sulphate), the 50 kD (GlyCAM-1), 90 kD (CD34) and 200 kD (Sgp200) bands quantified. The data are expressed as the percentage of the normal unprimed peripheral lymph nodes. The results shown are representative of ten similar experiments, in which no less than four mice were sacrificed at each time point.
associated with both the organ culture supernatants and lysates dropped by -85-95 % 3-4 days after exposure to arntigen ( Fig. 2 ) and were returning to normal levels 7 days after priming. Levels of Sgp200 in the supernatants dropped following immune challenge (Figs 2a and 2d ), but the levels of Sgp200 and CD34 in the lysates remained steady following antigenic stimulation (Figs 2c and 2e). Northern blot analysis revealed that 3-5 days after antigenic stimulation there was a 90-95 % reduction in the level of GlyCAM-1 messenger (m)RNA (Fig. 3a ). In contrast, the level of CD34 mRNA remained robust during this period (data not shown). These data clearly demonstrate that following antigenic stimulation there is a dramatic reduction in the levels of GlyCAM-1.
The decrease in GlyCAM-1 and Sgp200 synthesis is localized to the antigen-primed lymph node and is independent of the type of antigenic stimulus
The application of contact sensitisers such as oxazalone can, on occasion, result in a generalized priming of all peripheral lymph nodes due to animal grooming habits. Thus, to determine whether the decrease in secreted GlyCAM-1 and Sgp200 was specifically related to antigenic stimulation, animals were immunized subcutaneously with sheep red blood cells (SRBC) in Ribi adjuvant. This treatment results in the local priming, as determined by increased size, of only the popliteal lymph node and, occasionally, the inguinal lymph node on one side of the animal -that is, the draining lymph nodes. The same lymph nodes from the other side of the animal -the contralateral lymph nodes -that are not primed can be used as an internal control. Four days later the draining and contralateral lymph nodes were removed separately from the same SRBC-primed animal and labeled in vitro with 13
5 S]sodium sulphate. As a further control, the same peripheral lymph nodes were also removed from naive animals and sulphate-labeled. Only
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mRNA, as compared to the contralateral (unprimed) peripheral lymph node (Fig. 3b) or to peripheral lymph nodes from naive animals (data not shown). This decrease was independent of the nature of the antigen as similar results were obtained from animals that were primed with SRBC, oxazolone or KLH in adjuvant (data not shown).
Fig. 3.
Northern analysis of GlyCAM-1 mRNA levels. (a) RNA isolated from the peripheral lymph nodes of naive and oxazolone-treated mice at the times shown, and the GlyCAM-1 mRNA levels were analyzed as described in Materials and methods. As a loading control, the same blot was probed with the mouse actin cDNA; the low levels of actin message in the day 0 and day 1 samples are due to the fact that less RNA was loaded at these time points. (b) RNA isolated from either the popliteal lymph nodes that were primed with oxazolone or SRBC 4 days earlier (+), or the unprimed contralateral nodes (-). nodes exposed to antigen showed a 2-3 fold decrease in the level of sulphate incorporation and dramatic decreases (-5 % normal levels) in the levels of Gly-CAM-1 and Sgp200 in the supernatant (Fig. 4) . Once again, northern analysis of GlyCAM-1 mRNA levels revealed that 4 days following antigenic stimulation there was a 90-95 % reduction in the level of GlyCAM-1
Expression of L-selectin ligands following antigenic stimulation
Although the preceding data demonstrate that GlyCAM-1 secretion is down-regulated during an immune response, it remained a possibility that GlyCAM-1 (despite the fact that it is not a membrane-bound protein) somehow remains loosely associated with the HEV in the surrounding glycocalyx. To examine this possibility, we carried out an immunohistochemical analysis, using polyclonal Gly-CAM-1 and CD34 antisera (Fig. 5 ) and L-selectin-IgG (Fig. 6 ), of lymph nodes from animals primed with oxazolone. The first point to note is that CD34 staining remained robust at all time points (Fig. 5) . GlyCAM-1 staining, on the other hand, was intense in unprimed animals (day 0) but exhibited a dramatic decrease 1 day after priming with oxazolone. Staining was minimal 3 days after exposure to oxazolone but was increasing in intensity by day 7 and was normal after 10 days. L-selectin-IgG staining was intense at day 0, reduced in intensity at days 3 and 7 after antigen priming and attained normal levels by day 10.
The decrease in GlyCAM-1 synthesis scen in cultured peripheral lymph nodes was thus reflected in a decrease in immunohistochemical staining of the peripheral lymph node HEV. In addition, immunohistochemical analysis showed that L-selectin-IgG is still capable of binding to the HEV of primed peripheral lymph nodes (Fig. 6) ; the staining is, however, reduced in intensity at days 3 and 7. These data suggest that, although the Gly-CAM-1 ligand accounts for a large percentage of the staining seen in resting peripheral lymph nodes, in primed lymph nodes the major L-selectin ligands are CD34 and Sgp200.
Migration of naive cells into an inflamed peripheral lymph nodes is L-selectin dependent
The experiments described above raised the question of whether the migration of cells to antigen-primed lymph nodes became L-selectin independent. To address this issue, a migration experiment was performed using naive peripheral-lymph-node cells. The cells were labeled with [ 5 lCr]sodium chromate, mixed with either MEL-14 (an anti-L-selectin blocking monoclonal antibody; [17, 18] ), or isotype-matched normal rat IgG 2 a, and injected into syngeneic recipients that were either unprimed (day 0), or primed with oxazolone 4 hours or 1, 2, 3, 4, 7, 10 or 14 days earlier. After 2 hours the animals were sacrificed and the tissues described in the Materials and methods were collected. Although only the data for the peripheral lymph node are shown, other tissues were collected in order to ensure that either treatment of the cells with antibody or the induction of an immune response does not perturb the overall migration patterns; such perturbations were not seen. The peripheral lymph nodes were weighed prior to counting and the radioactivity expressed as c.p.m. per node. The results of these experiments (Fig.  7) clearly show that migration of naive lymphocytes to peripheral lymph nodes is L-selectin dependent, regardless of whether the peripheral lymph nodes are naive or antigen-primed. If the counts are expressed as c.p.m. per node, then it can be seen that more lymphocytes migrated to the antigen-primed peripheral lymph node; this increase parallels the increase in size of the peripheral lymph node following antigenic stimulation.
Discussion
These studies confirm the existence of a third L-selectinspecific ligand, Sgp200, and suggest that this molecule is associated with the peripheral lymph node as well as Immunohistochemical staining with L-selectin-lgG of an HEV in a naive peripheral lymph node (day 0) or peripheral lymph nodes at 3, 7 and 10 days after priming with oxazolone. Cryostat sections (6-8 im in thickness) from control or immunized lymph nodes were stained with gold-conjugated L-selectin-lgG (5 pIg per section); bound L-selectin-lgG was detected by silver enhancement. These data are representative of two experiments in which each group contained six mice. being secreted. Sgp200 is also present in normal mouse serum and is immunologically distinct from GlyCAM-1 and CD34. On induction of a primary immune response, the levels of GlyCAM-1 and Sgp200 in the supernatants of the peripheral lymph node organ cultures fall to almost undetectable levels, while the levels of Sgp200 in cell lysates remain essentially normal. At the same time, the levels of sulphated CD34 and its cell-surface expression remain virtually unchanged. These results suggest that Sgp200 may exist as both a secreted and a cell-associated molecule. Another possibility is that there are two molecules of similar molecular mass, one of which, like GlyCAM-1, is secreted and the other of which, like CD34, is cell-associated. The migration of lymphocytes to lymph nodes that have down-regulated their secretion of GlyCAM-1 and Sgp200 is still dependent on L-selectin. Rosen and colleagues [19] have also studied Sgp200 and have shown that it is MECA-79-reactive and requires sulphate for its interaction with L-selectin. MECA-79 is a monoclonal antibody that recognizes peripheral lymph node HEV [7] and, more specifically, sulphated carbohydrates that are critical for the interaction of L-selectin with its ligands [19] .
Our finding that there are at least two L-selectin ligands, GlyCAM-1 and Sgp200, that can be secreted raises the issue of the physiological significance of the soluble L-selectin ligands. One possibility is that they competitively inhibit cell migration to resting peripheral lymph nodes. This is an attractive theory in the light of the observations that only 25 % of lymphocytes that enter an unstimulated lymph node from the blood undergo extravasation, and that adhesion to HEVs is selective for T and B cells with the exclusion of other leukocytes [20, 21] . Following the induction of an immune response, an increased number of lymphocytes migrate to the primed lymph node in an L-selectin-dependent manner; elevated levels of other cell types, such as monocytes and neutrophils, which can bind to the HEV, are also found in the primed lymph node. Therefore, another possibility is that soluble L-selectin ligands act to modulate the adhesion of various subsets of cells to the peripheral lymph node during an immune response.
Although L-selectin was originally described as an adhesion molecule involved only in the migration of lymphocytes to peripheral lymph nodes [10] , subsequent studies have shown that this molecule is expressed on all leukocytes, except memory T cells [22] . L-selectin also seems to be crucial for mediating the influx of other white blood cells, such as neutrophils and monocytes, into acute inflammatory sites. For example, Marchesi and Gowans [23] demonstrated that neutrophils are able to bind to HEVs, and it was later demonstrated that circulating neutrophils bind HEVs more readily following antigenic challenge of the lymph node [22] . In addition, it has been shown that monocytes bind poorly, if at all, to the HEV of unstimulated peripheral lymph nodes but bind actively and in an L-selectin-dependent manner to the HEV of peripheral lymph nodes taken from animals 3 days after antigen priming [24] .
The suggestion that, during an immune response, there is an increase in the number of neutrophils and monocytes in a lymph node is not new [25, 26] , and our own fluorescence-activated cell sorting (FACS) analysis of peripheral lymph nodes from mice that had been primed with oxazolone 3-5 days earlier confirm these observations. We found that, in comparison to unprimed controls, the number of T and B cells in the primed peripheral lymph node increased -1.5 fold and 4-5 fold, respectively, and that the number of monocytes/macrophages increased by 7-9 fold (N. Ehsani and S.R.W, unpublished observations). Thus, in addition to the possibility that GlyCAM-1 and/or Sgp 2 00 may play a role as competitive regulators of lymphocyte migration, these molecules may also be involved in modulating the entry of neutrophils and monocytes into peripheral lymph nodes or acute inflammatory sites. Whether these molecules both perform the same function, or whether one acts upon monocytes and neutrophils and the other competes with lymphocytes for Lselectin ligands on HEVs, is a matter open to conjecture. Another interpretation of the data is that the soluble selectin ligands may be involved in cell signaling. The results presented here indicate that CD34 or Sgp200 are sufficient to mediate adhesion of lymphocytes, via Lselectin, to the peripheral lymph node HEV at a time when the levels of soluble GlyCAM-1 and Sgp200 are decreased. We speculate that the decrease in soluble Lselectin ligands, either locally or systemically, results in the increased occupancy of L-selectin on the HEV surface by other ligands, such as CD34 or Sgp 2 00, at the time of antigen challenge. This higher L-selectin occupancy by the HEV-associated ligands might induce a preactivation signal in naive lymphocytes that enables them to cope more efficiently with the antigenic insult. Furthermore, because it has been shown that CD34 can be phosphorylated after stimulation with phorbol esters in some cell types [27] , and that anti-CD34 antibodies may induce cellular aggregation [28] , it is possible that the engagement of a increased number of CD34 or Sgp200 molecules on the endothelial cell surface by lymphocyte L-selectin could lead to a change in adhesive properties of the HEV.
It is worth noting that the use of the total protein content in lymph nodes as the baseline against which GlyCAM-1 expression is measured may introduce a distortion into the quantification of our data. As is apparent in Figures 5  and 7 , lymph nodes that drain the sites of antigen injection or skin-painting with haptens increase substantially in size. Therefore, it is possible that, if the HEV cell content does not increase in size in parallel with the lymph node, the expression of GlyCAM-1 may be underestimated. Previous studies have shown that there is also an increase in the surface area of the HEV during antigenic stimulation [29] , however, this increase lags behind the increase in size observed in the T cell-dependent areas of the lymph node, thus making quantification of the relative increases difficult. It may be possible in the future to use another marker that, while specific for HEV, is not altered by the induction of an immune response and would therefore allow a more accurate standardization of the data. Nevertheless, these results, together with the immunohistochemistry data, do indicate that GlyCAM-1 is down-regulated during an immune response; the down-regulation is maximal 3-4 days after antigenic stimulation and GlyCAM-1 levels return to normal 7-10 days after antigenic challenge.
Conclusions
These studies demonstrate that there are three L-selectin ligands present in naive lymph nodes. Two of these ligands, Sgp200 and GlyCAM-1, are secreted from resting lymph nodes and are down-regulated during an immune response; Sgp200 is also associated with the HEV cell surface. It is not clear whether the cell surface and secreted forms of Sgp200 are the same -molecular characterization will be necessary in order to determine their relationship to one another. If the secreted and cell-associated forms of Sgp200 are different, alternative RNA splicing may be responsible; if this is the case then it will be interesting to determine whether the splicing event itself is regulated by an immune response. Finally, it is possible that lymphocyte migration should not be thought of as the simple interaction of a receptor on the surface of lymphocytes with its cognate ligand on the HEV surface. In a resting peripheral lymph node there may be competition for these interactions; following the induction of an immune response this competition may be reduced, thus allowing a more diverse cell population to enter the lymph node.
Materials and methods
Animals and antigen priming
Six to eight week old BALB/c female mice were used throughout these studies. They were primed with either a 1 % solution of oxazolone (Sigma), which was painted on the animal in the groin and shoulder areas to induce a response in the brachial, axillary, inguinal, cervical and popliteal lymph nodes, or 2 % sheep red blood cells (SRBC) in Ribi adjuvant or 200 [pg keyhole limpet haemocyanin (KLH) in Ribi adjuvant. The latter reagents were administered subcutaneously in a volume of 25 pxl and induced responses only in the draining popliteal lymph nodes and occasionally the inguinal lymph nodes on the same side of the animal.
Chimeric proteins
The L-selectin-IgG chimera and its production, purification and biological properties have been extensively described [9] . The CD4-IgG control chimera, has been described by Capon et al. [30] .
Immunohistochemical staining of HEV with L-selectin-lgG
The L-selectin-IgG chimera was conjugated to 10 nm gold particles (electron microscopic grade; Zymed) and used to stain 6-8 pLm thick cryostat sections of murine peripheral lymph nodes that had been fixed in ice-cold acetone. Sections were preincubated with Dulbecco's phosphate-buffered saline (D-PBS)/0. 1 % BSA containing 200 ,pg m1-1 CD4-IgG. After the removal of this material the gold-conjugated chimera was added at a concentration of 50 Izg ml-1 in D-PBS containing 200 pLg ml-1 CD4-lgG. The staining was performed at 4 °C with rotation at 65 r.p.m. for 40 minutes. After this time the gold conjugate was gently decanted and the sections slowly immersed in 2.5 % glutaraldehyde in D-PBS. The staining was silver-enhanced using the Enhance kit (Amersham) prior to counterstaining of the sections with aqueous haematoxylin (Biomeda). Sections were mounted in cystal mount (Biomeda) for microscopic observation.
Immunohistochemical staining of sections with anti-
GlyCAM-I and anti-CD34 polyclonal antisera
Immunohistochemistry was performed as previously described on either fresh-frozen or periodate-lysine-paraformaldehyde (PLP) fixed tissue sections [31] . Briefly, 5-8 (pm paraffin sections were deparaffinized in xylene for 10 minutes, rinsed in water, and endogenous peroxidase activity was quenched with 1 % H, 2 0 2 for 30 minutes. For staining with the anti-CD34 antibody, sections were immersed in 0.1 M citrate buffer (pH 6.0) and microwaved twice on high power for 3 minutes followed by 20 minutes at room temperature. For staining with the anti-GlyCAM-1 antibody the citrate antigen-retrieval step was replaced by a 3 minute pepsin digestion at 37 °C. Nonspecific binding was blocked by a 30 minute preincubation with 10 % normal mouse serum and followed by a 30 minute room-temperature incubation with the appropriate dilution of antibody. Sections were rinsed in PBS, incubated with biotinylated goat-anti-rabbit IgG (Vector Laboratories) for 30 minutes, rinsed again and incubated with the Vector Elite ABC reagents (streptavidin-horseradish peroxidase conjugate) as specified by the manufacturer's instructions. Substrate (diaminobenzidine (DAB), Dako) was added for 5 minutes and staining was enhanced by a 10 second incubation with a DABenhancing solution (Vector Laboratories), used according to the manufacturer's instructions. Sections were counterstained with Mayer's haematoxylin, dehydrated, and mounted in synthetic mounting medium.
In vitro organ culture Peripheral lymph nodes were aseptically removed from antigen-primed or unstimulated mice, the excess fatty tissue was detatched and the lymph nodes were sliced into 1-2 mm pieces. The slices were cultured in 1 ml D-PBS (containing 10 Vpg ml -t glucose and antibiotics) in the presence of 250 luCi [ 35 S]sodium sulphate (ICN Radiochemicals); the organ culture was carried out at 37 °C in humidified air containing 5 % CO 2 . After 3 hours the supernatants were removed from the cultures. The tissue slices were washed three times with D-PBS, after which lysis buffer (1 ml D-PBS containing 2 % Triton X100, 0.1 % sodium azide and 10 units aprotinin) was added and the tissue disintegrated with the aid of a Tissuemizer (Baxter). Lysis was continued for a further 30 minutes at 4 °C and was followed by centrifugation of the lysates and supernatants at 5 000 x g. The resulting materials were precleared overnight at 4 C by the addition of protein A-Sepharose (Pharmacia) as described by Imai et al. [14] . Prior to using the sulphate-labeled material the protein concentrations were determined using the BCA protein assay reagent (Pierce). Sulphate incorporation was calculated by determining the acetone-precipitable radioactivity obtained from 100 ul of labeled lysate. For all immunoprecipitations described in these studies equal amounts of protein were used.
In vivo-labeling experiments Mice were injected intravenously with 1 mCi [
35 S]sodium sulphate; 4 hours later the animals were exsanguinated and the peripheral and mesenteric lymph nodes and Peyer's patches were removed. The blood was allowed to clot at room temperature and was placed at 4 °C overnight to allow retraction of the clot and the removal of serum. The organs were lysed as described above and the immunoprecipitations with L-selectin-IgG, anti-GlyCAM-1 and anti-CD34 antibodies performed as described below. All immunoprecipitations were carried out using equal amounts of protein.
Radioimmunoprecipitations of L-selectin ligands
Radioimmunoprecipitations using purified L-selectin-IgG (30 ig ml -t ) were performed as described by Imai et al. [14] . Radioimmunoprecipitations using polyclonal antisera against GlyCAM-1 and CD34 were performed as described in Lasky et al. [10] and Baumhueter et al. [12, 31] , respectively.
Northern blot analysis
Agarose-formaldehyde gel electrophoresis in MOPS buffer of RNA samples was carried out as described [3] . RNA was directly transferred using a Posiblot apparatus (Stratagene, La Jolla, California) for 45 minutes onto Bioblot NC nitrocellulose (Costar, Cambridge, Massachusetts). GlyCAM-1 and actin RNAs were visualized by hybridization with the appropriate [ 32 p] radiolabeled probe generated by random priming as described [32] .
Lymphocyte migration in vivo
Peripheral lymph nodes were removed from naive BALB/c mice and single-cell suspensions were prepared and labeled with [5 1 Cr] sodium chromate as previously described [33] . The labeled cells were washed and mixed with either MEL-14 or rat IgG 2 (100 sIg per 106 cells) and 4 x 106 cells injected into syngeneic recipients that were either naive or had been systemically primed with oxazolone 4 hrs or , 2, 3, 4, 7, 10 or 14 days earlier. Two hours after injection the recipients were bled for a 50 l blood sample, cervically dislocated and the peripheral and mesenteric lymph nodes, Payer's patches, spleen, liver, lungs, and thymus were removed for quantitation\ of radioactivity in a gamma counter. The antigen-primed and naive lymph nodes were weighed and the number of counts present in these tissues expressed as c.p.m. per peripheral lymph node. Each animal received between 150 000 and 165 000 total c.p.m. and 2 hours later only 134-155 c.p.m. remained in a 50 l1 sample of blood in all groups.
